Cargando…
ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients
Colorectal cancer (CRC) is a heterogeneous disease with a high mortality rate and is still lacking an effective treatment. Our goal is to develop a robust prognosis model for predicting the prognosis in CRC patients. In this study, 871 stage II and III CRC samples were collected from six gene expres...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
PeerJ Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793313/ https://www.ncbi.nlm.nih.gov/pubmed/26989635 http://dx.doi.org/10.7717/peerj.1804 |